Literature DB >> 17828506

Malignant phenotype of PC3 cell line was inhibited by siRNA targeting PAR gene.

Xiaofeng Xu1, Siwei Zhou, Zhengyu Zhang, Jingping Ge, Wen Cheng, Zhifeng Wei, Xu Zhang, Jianping Gao.   

Abstract

To investigate the effects of down-regulation of prostate androgen regulated (PAR) expression on proliferation of PC3 cells by using RNA interference (RNAi), suppression of PAR expression was achieved by transfection of PC3 cells with short hairpin RNA (shRNA) expression vectors against PAR, designated as psiRNA-PAR1, psiRNA-PAR2 and psiRNA-PAR3. The inhibitory effects were confirmed by RT-PCR. The growth features of PC3 transfectants were analyzed by cell counts, colon formation in soft agar and flow cytometry. The expression of PAR was suppressed by the three shRNA expression vectors. psiRNA-PAR1 was shown to inhibit the PAR expression most efficiently, with the inhibitory rate reaching a peak at (81.18+/-1.68)% 48 h after the transfection. PC3 transfectants exhibited a decreased proliferation in cell culture and a low efficiency of colon formation in soft agar. Flow cytometry revealed a G(2)/M arrest and induced apoptosis. Down-regulated PAR expression inhibited the growth of PC3 cells by inducing G(2)/M arrest and activating apoptotic pathway. As a potential proto-oncogene that triggers and/or has persistent malignant proliferation, PAR may serves as a very target for the gene therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828506     DOI: 10.1007/s11596-007-0423-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  15 in total

1.  A simple and cost-effective method for producing small interfering RNAs with high efficacy.

Authors:  Muhammad Sohail; Graeme Doran; Johann Riedemann; Val Macaulay; Edwin M Southern
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

2.  Rational siRNA design for RNA interference.

Authors:  Angela Reynolds; Devin Leake; Queta Boese; Stephen Scaringe; William S Marshall; Anastasia Khvorova
Journal:  Nat Biotechnol       Date:  2004-02-01       Impact factor: 54.908

Review 3.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

Review 4.  Killing the messenger: antisense DNA and siRNA.

Authors:  M Nesterova; Y S Cho-Chung
Journal:  Curr Drug Targets       Date:  2004-11       Impact factor: 3.465

5.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

Review 6.  Molecular biology of prostate cancer.

Authors:  X B Shi; P H Gumerlock; R W deVere White
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 7.  Androgen deprivation therapy for prostate cancer: current status and future prospects.

Authors:  Hiroshi Miyamoto; Edward M Messing; Chawnshang Chang
Journal:  Prostate       Date:  2004-12-01       Impact factor: 4.104

Review 8.  Genetic characteristics of prostate cancer.

Authors:  M Huncharek; J Muscat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995-09       Impact factor: 4.254

Review 9.  Oncogenes as regulators of apoptosis.

Authors:  Mohamed Labazi; Andrew C Phillips
Journal:  Essays Biochem       Date:  2003       Impact factor: 8.000

10.  Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Authors:  Lisa G Horvath; Susan M Henshall; James G Kench; Jennifer J Turner; David Golovsky; Phillip C Brenner; Gordon F O'Neill; Raji Kooner; Phillip D Stricker; John J Grygiel; Robert L Sutherland
Journal:  Prostate       Date:  2004-05-15       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.